Dale Muzzey Myriad Genetics Inc (MYGN) insider trading activity

Dale Muzzey is Chief Scientific Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 107,144 shares of MYGN, which is worth approximately $1.32 Million. The most recent transaction as insider was on Jan 01, 2025, when has been sold 417 shares (Common Stock) at a price of $13.71 per share, resulting in proceeds of $5,717. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

0.39% 3M change

58.8% 12M change

Total Value Held $1.32 Million

Dale Muzzey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2025	SELL Payment of exercise price or tax liability	$5,717 $13.71 p/Share	417 Reduced 0.39%	107,144 Common Stock
Oct 09 2024	SELL Payment of exercise price or tax liability	$11,015 $24.37 p/Share	452 Reduced 0.42%	107,561 Common Stock
Sep 11 2024	SELL Open market or private sale	$54,957 $26.17 p/Share	2,100 Reduced 1.91%	108,013 Common Stock
Apr 14 2024	SELL Payment of exercise price or tax liability	$18,377 $19.55 p/Share	940 Reduced 0.85%	110,113 Common Stock
Mar 24 2024	SELL Payment of exercise price or tax liability	$20,972 $22.24 p/Share	943 Reduced 0.84%	111,053 Common Stock
Mar 22 2024	SELL Payment of exercise price or tax liability	$31,247 $22.24 p/Share	1,405 Reduced 1.24%	111,996 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$70,293 $21.16 p/Share	3,322 Reduced 2.85%	113,401 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	49,250 Added 29.67%	116,723 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$5,799 $19.14 p/Share	303 Reduced 0.45%	67,473 Common Stock
Oct 09 2023	SELL Payment of exercise price or tax liability	$4,623 $15.01 p/Share	308 Reduced 0.45%	67,776 Common Stock
Sep 26 2023	SELL Payment of exercise price or tax liability	$2,126 $15.99 p/Share	133 Reduced 0.19%	68,084 Common Stock
Apr 14 2023	SELL Payment of exercise price or tax liability	$14,208 $22.27 p/Share	638 Reduced 0.93%	68,217 Common Stock
Mar 24 2023	SELL Payment of exercise price or tax liability	$21,751 $23.72 p/Share	917 Reduced 1.31%	68,855 Common Stock
Mar 22 2023	SELL Payment of exercise price or tax liability	$32,051 $22.91 p/Share	1,399 Reduced 1.97%	69,772 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	28,459 Added 28.56%	71,171 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$4,382 $14.51 p/Share	302 Reduced 0.7%	42,712 Common Stock
Oct 09 2022	SELL Payment of exercise price or tax liability	$6,063 $19.62 p/Share	309 Reduced 0.71%	43,014 Common Stock
Sep 26 2022	SELL Payment of exercise price or tax liability	$2,449 $18.41 p/Share	133 Reduced 0.31%	43,323 Common Stock
Sep 25 2022	SELL Payment of exercise price or tax liability	$6,448 $18.69 p/Share	345 Reduced 0.79%	43,456 Common Stock
Apr 14 2022	BUY Grant, award, or other acquisition	-	7,500 Added 14.62%	43,801 Common Stock

Dale Muzzey

Chief Scientific Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Value

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN

Account